Survival rates improving for many Americans with a variety of cancers
the ONA take:
According to a new report published in the journal JAMA Oncology, researchers from the Cancer Epidemiology Research Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, have found that survival rates are improving for many people with breast, colon, liver, lung, and prostate cancer.
Survival rates are particularly improving for those diagnosed at younger ages. The researchers also observed differences in survival based on race.
Specifically, blacks had poorer survival compared with whites. Of note, results showed black women with ovarian cancer experienced an increase in risk of death over the last 20 years.
In addition, many patients aged 50 to 64 with breast, colorectal, liver, or prostate cancer had significantly increased odds of survival, but patients aged 75 to 85 with the same cancers had smaller decreases in risk of death.
For the study, researchers analyzed data on over 1 million patients diagnosed with breast, colorectal, liver, lung, ovarian, pancreatic, or prostate cancer between 1990 and 2009 from the U.S. National Cancer Institute Surveillance, Epidemiology and End Results (SEER) study.
A cancer false alarm may give false sense of security
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|